• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用回顾性全科医生数据库分析评估比利时抗生素的使用情况和水痘负担。

Assessing the use of antibiotics and the burden of varicella in Belgium using a retrospective GP database analysis.

机构信息

MSD, Clos du Lynx 5, Sint-Lambrechts-Woluwe, 1200, Brussels, Belgium.

Real World Evidence, IQVIA, Zaventem, Belgium.

出版信息

BMC Infect Dis. 2021 Nov 11;21(1):1150. doi: 10.1186/s12879-021-06848-4.

DOI:10.1186/s12879-021-06848-4
PMID:34758734
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8582146/
Abstract

BACKGROUND

Varicella is a highly contagious infection that typically occurs in childhood. While most cases have a generally benign outcome, infection results in a considerable healthcare burden and serious complications may occur.

OBJECTIVES

The objective of this study was to characterize the burden of varicella in a real-world primary care setting in Belgium, including the rate of varicella-related complications, medication management and general practitioner (GP) visits.

METHODS

The study was a retrospective observational study using data from a longitudinal patient database in a primary care setting in Belgium. Patients with a GP visit and a varicella diagnosis between January 2016 and June 2019 were eligible and data one month prior and three months after the diagnosis were included. Outcomes included varicella-related complications, antibiotic use, antiviral use, and GP follow-up visits. Antibiotic use could be specified by class of antibiotic and linked to a diagnosis. Complications were identified based on concomitant diagnosis with varicella during the study period.

RESULTS

3,847 patients with diagnosis of varicella were included, with a mean age of 8.4 years and a comparable distribution of gender. 12.6% of patients with varicella had a concomitant diagnosis of a varicella-related complication. During the follow-up period, 27.3% of patients with varicella were prescribed antibiotics, either systemic (19.8%) and/or topical (10.3%). The highest rate of antibiotic prescriptions was observed in patients with complications (63.5%) and in patients younger than 1 year (41.8%). Nevertheless, 5.3% of the patients were prescribed antibiotics without a concomitant diagnosis of another infection. The most commonly prescribed systemic antibiotics were amoxicillin alone or combined with beta-lactamase inhibitor, and thiamphenicol. Fusidic acid and tobramycin were the most prescribed topical antibiotics. Antivirals were prescribed for 2.7% of the study population. 4.7% of the patients needed a follow-up visit with their GP.

CONCLUSIONS

This study reports a substantial burden of varicella in a primary care setting in Belgium, with high rates of complications and antibiotic use.

摘要

背景

水痘是一种高度传染性的感染,通常发生在儿童时期。虽然大多数病例的结局通常良好,但感染会导致相当大的医疗保健负担,并且可能发生严重的并发症。

目的

本研究旨在描述比利时初级保健环境中水痘的负担,包括水痘相关并发症的发生率、药物管理和全科医生(GP)就诊情况。

方法

这是一项回顾性观察性研究,使用了比利时初级保健环境中纵向患者数据库的数据。2016 年 1 月至 2019 年 6 月期间,有 GP 就诊和水痘诊断的患者符合条件,并纳入了诊断前一个月和后三个月的数据。结果包括水痘相关并发症、抗生素使用、抗病毒药物使用和 GP 随访就诊。抗生素的使用可按抗生素类别进行指定,并与诊断相关联。并发症是根据研究期间与水痘同时诊断出来的。

结果

纳入了 3847 例水痘诊断患者,平均年龄为 8.4 岁,性别分布相当。12.6%的水痘患者同时诊断出与水痘相关的并发症。在随访期间,27.3%的水痘患者使用了抗生素,包括全身(19.8%)和/或局部(10.3%)。在有并发症的患者(63.5%)和年龄小于 1 岁的患者(41.8%)中,抗生素的处方率最高。然而,5.3%的患者在没有合并另一种感染诊断的情况下使用了抗生素。最常开的全身抗生素是阿莫西林单独或与β-内酰胺酶抑制剂联合使用,以及噻苯青霉素。夫西地酸和妥布霉素是最常开的局部抗生素。抗病毒药物用于 2.7%的研究人群。4.7%的患者需要与他们的 GP 进行随访就诊。

结论

本研究报告了比利时初级保健环境中水痘的负担很大,并发症和抗生素的使用率都很高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a89/8582146/55496637207b/12879_2021_6848_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a89/8582146/c1dc3d4d925e/12879_2021_6848_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a89/8582146/6117d8318497/12879_2021_6848_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a89/8582146/55496637207b/12879_2021_6848_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a89/8582146/c1dc3d4d925e/12879_2021_6848_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a89/8582146/6117d8318497/12879_2021_6848_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a89/8582146/55496637207b/12879_2021_6848_Fig3_HTML.jpg

相似文献

1
Assessing the use of antibiotics and the burden of varicella in Belgium using a retrospective GP database analysis.使用回顾性全科医生数据库分析评估比利时抗生素的使用情况和水痘负担。
BMC Infect Dis. 2021 Nov 11;21(1):1150. doi: 10.1186/s12879-021-06848-4.
2
The use of antibiotics in the treatment of pediatric varicella patients: real-world evidence from the multi-country MARVEL study in Latin America & Europe.抗生素在儿科水痘患者治疗中的应用:来自拉丁美洲和欧洲多国 MARVEL 研究的真实世界证据。
BMC Public Health. 2019 Jun 26;19(1):826. doi: 10.1186/s12889-019-7071-z.
3
The Clinical and Economic Burden of Antibiotic Use in Pediatric Patients With Varicella Infection: A Retrospective Cohort Analysis of Real-World Data in England.《英国真实世界数据回顾性队列分析:儿童水痘感染患者抗生素使用的临床和经济负担》。
J Infect Dis. 2024 Jul 25;230(1):e65-e74. doi: 10.1093/infdis/jiad420.
4
Clinical and Economic Burden of Antibiotic Use Among Pediatric Patients With Varicella Infection in the Outpatient Setting: A Retrospective Cohort Analysis of Real-world Data in France.门诊小儿水痘感染患者抗生素使用的临床和经济负担:法国真实世界数据的回顾性队列分析。
Pediatr Infect Dis J. 2024 Apr 1;43(4):393-399. doi: 10.1097/INF.0000000000004254. Epub 2024 Feb 16.
5
Antimicrobial use for the management of varicella in Thailand: a retrospective observational study.泰国水痘管理中的抗菌药物使用:一项回顾性观察研究。
Curr Med Res Opin. 2023 Jun;39(6):873-880. doi: 10.1080/03007995.2023.2200123. Epub 2023 Apr 27.
6
Varicella paediatric hospitalisations in Belgium: a 1-year national survey.比利时水痘患儿住院情况:一项为期一年的全国性调查。
Arch Dis Child. 2016 Jan;101(1):16-22. doi: 10.1136/archdischild-2015-308283. Epub 2015 Jun 30.
7
Assessing the use of antibiotics in pediatric patients hospitalized for varicella.评估住院治疗水痘的儿科患者中抗生素的使用情况。
Ital J Pediatr. 2022 Dec 12;48(1):196. doi: 10.1186/s13052-022-01393-5.
8
Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands.荷兰水痘带状疱疹病毒的流行病学特征和社会负担。
BMC Infect Dis. 2012 May 10;12:110. doi: 10.1186/1471-2334-12-110.
9
Low varicella-related consultation rate in the Netherlands in primary care data.荷兰初级保健数据中与水痘相关的咨询率较低。
Vaccine. 2014 Jun 12;32(28):3517-24. doi: 10.1016/j.vaccine.2014.04.034. Epub 2014 May 2.
10
Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease.非甾体抗炎药的使用与水痘或带状疱疹患者发生严重皮肤和软组织并发症的风险
Br J Clin Pharmacol. 2008 Feb;65(2):203-9. doi: 10.1111/j.1365-2125.2007.02997.x.

引用本文的文献

1
The Clinical and Economic Burden of Antibiotic Use in Pediatric Patients With Varicella Infection: A Retrospective Cohort Analysis of Real-World Data in England.《英国真实世界数据回顾性队列分析:儿童水痘感染患者抗生素使用的临床和经济负担》。
J Infect Dis. 2024 Jul 25;230(1):e65-e74. doi: 10.1093/infdis/jiad420.
2
Clinical and Economic Burden of Antibiotic Use Among Pediatric Patients With Varicella Infection in the Outpatient Setting: A Retrospective Cohort Analysis of Real-world Data in France.门诊小儿水痘感染患者抗生素使用的临床和经济负担:法国真实世界数据的回顾性队列分析。
Pediatr Infect Dis J. 2024 Apr 1;43(4):393-399. doi: 10.1097/INF.0000000000004254. Epub 2024 Feb 16.
3

本文引用的文献

1
Clinical and economic impact of universal varicella vaccination in Norway: A modeling study.挪威水痘疫苗普遍接种的临床和经济影响:一项建模研究。
PLoS One. 2021 Jul 8;16(7):e0254080. doi: 10.1371/journal.pone.0254080. eCollection 2021.
2
Office-based approach to urinary tract infections in 50 000 patients: results from the REWIND study.50000 例患者尿路感染的基于门诊的处理方法:REWIND 研究结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105966. doi: 10.1016/j.ijantimicag.2020.105966. Epub 2020 Apr 20.
3
Antibiotic use and resistance in Belgium: the impact of two decades of multi-faceted campaigning.
Assessing the use of antibiotics in pediatric patients hospitalized for varicella.
评估住院治疗水痘的儿科患者中抗生素的使用情况。
Ital J Pediatr. 2022 Dec 12;48(1):196. doi: 10.1186/s13052-022-01393-5.
4
Available evidence and potential for vaccines for reduction in antibiotic prescriptions.减少抗生素处方的疫苗的现有证据和潜力。
Hum Vaccin Immunother. 2022 Dec 30;18(7):2151291. doi: 10.1080/21645515.2022.2151291. Epub 2022 Dec 5.
5
Vaccination coverage in Italian children and antimicrobial resistance: an ecological analysis.意大利儿童疫苗接种率与抗生素耐药性:生态分析。
Antimicrob Resist Infect Control. 2022 Nov 9;11(1):136. doi: 10.1186/s13756-022-01173-0.
比利时的抗生素使用与耐药性:二十年多方面宣传活动的影响
Acta Clin Belg. 2021 Aug;76(4):280-288. doi: 10.1080/17843286.2020.1721135. Epub 2020 Feb 5.
4
Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data.接触水痘后患带状疱疹的风险:使用英国电子医疗保健数据的自身对照病例系列研究,探索外源性增强假说。
BMJ. 2020 Jan 22;368:l6987. doi: 10.1136/bmj.l6987.
5
Varicella-zoster virus post-exposure management and prophylaxis: A review.水痘-带状疱疹病毒暴露后管理与预防:综述
Prev Med Rep. 2019 Nov 6;16:101016. doi: 10.1016/j.pmedr.2019.101016. eCollection 2019 Dec.
6
Specific Varicella-Related Complications and Their Decrease in Hospitalized Children after the Introduction of General Varicella Vaccination: Results from a Multicenter Pediatric Hospital Surveillance Study in Bavaria (Germany).引入水痘疫苗后住院儿童中特定的水痘相关并发症及其减少情况:德国巴伐利亚州一项多中心儿科医院监测研究的结果
Infect Dis Ther. 2019 Dec;8(4):597-611. doi: 10.1007/s40121-019-00273-6. Epub 2019 Oct 31.
7
Varicella zoster virus vaccines: an update.水痘带状疱疹病毒疫苗:最新进展
Immunotargets Ther. 2019 Aug 6;8:15-28. doi: 10.2147/ITT.S176383. eCollection 2019.
8
The use of antibiotics in the treatment of pediatric varicella patients: real-world evidence from the multi-country MARVEL study in Latin America & Europe.抗生素在儿科水痘患者治疗中的应用:来自拉丁美洲和欧洲多国 MARVEL 研究的真实世界证据。
BMC Public Health. 2019 Jun 26;19(1):826. doi: 10.1186/s12889-019-7071-z.
9
The Impact of Varicella Vaccination on the Incidence of Varicella and Herpes Zoster in the United States: Updated Evidence From Observational Databases, 1991-2016.水痘疫苗接种对美国水痘和带状疱疹发病率的影响:来自 1991-2016 年观察性数据库的最新证据。
Clin Infect Dis. 2020 Mar 3;70(6):995-1002. doi: 10.1093/cid/ciz305.
10
Gender differences in determinants of iron-deficiency anemia: a population-based study conducted in four European countries.铁缺乏性贫血决定因素的性别差异:在四个欧洲国家开展的一项基于人群的研究。
Ann Hematol. 2019 Jul;98(7):1573-1582. doi: 10.1007/s00277-019-03707-w. Epub 2019 May 9.